Mammography screening outcomes for women screened by standard versus high resolution digital breast tomosynthesis.

Melinda Talley¹, Kathryn Starzyk², Scott Pohlman³, Julia Olsen³, Paul Buzinec⁴, Jamie Williams¹

¹Sanford Health, Sioux Falls, SD, United States of America.

²OM1, Inc., Boston, MA, United States of America. Electronic address: kstarzyk@om1.com.

³Hologic, Inc., Marlborough, MA, United States of America.

⁴OM1, Inc., Boston, MA, United States of America.

PubMed DOI

Abstract

OBJECTIVE: This study compared breast cancer screening outcomes between high resolution (HR; 70-micron) and standard resolution (SR; 100-micron) digital breast tomosynthesis (DBT) systems in real-world practice. METHODS: This retrospective, observational cohort study included women ages 40-79 screened for breast cancer at a U.S. health system from 2013 to 2023. Cancer detection rate (CDR), recall…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.